Tandem PV Awarded $4M California Energy Commission Grant
Funding will support rigorous testing to validate the performance and durability of Tandem PV’s new perovskite solar manufacturing Tandem PV, a leader in next-generation solar...
Tag : commercialization
Canada Nickel Partners with NetCarb to Advance Carbon Sequestration Tech
Highlights Canada Nickel Company Inc. is pleased to announce a strategic partnership with Australia-based NetCarb to collaborate on the commercialization of NetCarb’s innovative carbon sequestration technology....
Agenus, Zydus in $141M Deal to Boost US Biologics Manufacturing
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), including its...
Clean Energy Systems Appoints Energy Tech Veteran Mark McGough as New CEO
Clean Energy Systems (CES), a pioneering force in carbon-free combustion technology and zero-emission power solutions, is thrilled to announce the appointment of Mark McGough as its new...
Pulnovo Gains EQT Investment After CE-MDR Approval
Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has received new investment from EQT Group, a...
EnviroGold Advances NVRO Process™ Toward Commercialisation
Process Optimisation, Strategic Alliances and Engineering Readiness Position Company for Market Entry EnviroGold Global Limited, a clean-technology leader in reprocessing mine tailings and waste to...
AriBio and Fujirebio Complete Sample Set for Alzheimer’s Biomarkers
Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. announced the completion of a prospective sample acquisition as part of the...
Cyprumed, MSD Sign Deal for Oral Peptide Therapeutics
Cyprumed GmbH, a dedicated drug delivery company specializing in innovative oral peptide formulations, and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), today...
ABL Bio Licenses Grabody-B Platform to GSK for Brain Drugs
ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases Programs will leverage ABL Bio’s Grabody-B platform technology to effectively deliver molecules across...
Spiritus Expands Direct Air Capture Team with Top Clean Energy Hires
Industry veterans from Babcock & Wilcox, LanzaTech, and other major players join Spiritus to bridge the gap between pilot and large-scale deployment Spiritus, the company...
PHC and Cyfuse Develop New Tech for 3D Cell Product Production
Breakthrough Will Support Development of New Circulation Cell Culture System to Enhance Quality and Stability of Manufacturing PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura;...
Xeltis Adds Leading Experts to Medical Advisory Board
Leading nephrologists Dr. An De Vriese and Dr. Monnie Wasse join as Company continues clinical advancement Xeltis, a leading developer of transformative implants that enable the natural...
Nielsen BioSciences Completes Enrollment in Phase 3 CANDIN Trial
325 subjects enrolled across the United States and Japan in the first Phase III clinical trial for the treatment of warts in children and adults....
CareDx Study: AlloSeq cfDNA Accurately Detects Organ Rejection
AlloSeq cfDNA Consistent with Performance of Proven AlloSure Testing CareDx Brings Innovative Non-Invasive Transplant Monitoring to Patients Internationally with AlloSeq cfDNA CareDx, Inc. (Nasdaq: CDNA)...
KORU Medical Announces Phase III Trial for New Nephrology Drug
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and...